Sep 16, 2021 | Clinical Trials, Globalization, Health, Healthcare, Pharmaceuticals
CSOFT Health Sciences sat down with Dr. Vladimir Misik, board member of leading European CRO, SanaClis, as well as Partner and Founder of LongTaal, and Partner and Co-founder of VIARES Academy, in our newest podcast episode of Coffee & Conversations to evaluate...
Jul 9, 2021 | Clinical Trials, Healthcare, Innovation, Medical Translation, Pharmaceuticals, Regulatory
On our most recent Coffee & Conversations podcast episode, podcast hosts Brigid and Shelby joined CSOFT’s President and CEO Shunee Yee and Professor Victoria Elegant, who serves as Vice-President of JAPAC Regional Medical Head of Amgen to discuss The Next...
Mar 10, 2021 | Pharmaceuticals, Regulatory
The U.S. Food and Drug Administration (FDA) cleared Melior Pharmaceuticals’ Investigational New Drug (IND) application for it’s COVID-19 therapeutic candidate, tolimidone. Taken as an oral pill once a day, Tolimidone is a novel lyn kase activator designed...
Feb 18, 2021 | Clinical Trials, e-Learning, Health, Pharmaceuticals, Regulatory
There is no doubt that clinical trials are vitally important in the drug development process. As an increasing number of clinical trials are conducted overseas, sometimes with multiple ongoing studies at once, having in-depth knowledge...
Jan 7, 2021 | Clinical Trials, Health, Language Service Provider, Medical Translation, Pharmaceuticals, Regulatory
With a population of more than 1.3 billion people, India is one of the fastest growing economies in the world. As their global economy continues to expand, and as clinical trials are continuing to be conducted overseas, India remains unique in both the opportunities...
Aug 21, 2020 | Clinical Trials, FDA, Globalization, Healthcare, Pharmaceuticals
One of the biggest areas of concern in the pharmaceutical industry, particularly in the United States, is the high costs of new treatments or drug therapies for patients. The recent initiatives from regulatory agencies like the Food and Drug Administration (FDA) to...
